|
PAPOLG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.81177295388579E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.37499994618184E-09 |
| Normal-vs-Stage2 |
4.63760000002367E-06 |
| Normal-vs-Stage3 |
1.98729921407903E-14 |
| Normal-vs-Stage4 |
3.10862446895044E-14 |
| Stage1-vs-Stage2 |
9.552400E-01 |
| Stage1-vs-Stage3 |
2.484600E-03 |
| Stage1-vs-Stage4 |
1.74778999999514E-05 |
| Stage2-vs-Stage3 |
3.537800E-02 |
| Stage2-vs-Stage4 |
3.758400E-03 |
| Stage3-vs-Stage4 |
1.632620E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.56519242011655E-12 |
| Normal-vs-AfricanAmerican |
1.626800000043E-06 |
| Normal-vs-Asian |
5.99780000110073E-08 |
| Caucasian-vs-AfricanAmerican |
8.185600E-01 |
| Caucasian-vs-Asian |
3.476400E-01 |
| AfricanAmerican-vs-Asian |
3.796600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.40309985852127E-10 |
| Normal-vs-Female |
2.66864308429149E-12 |
| Male-vs-Female |
9.341000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.25449994836657E-09 |
| Normal-vs-Age(41-60Yrs) |
6.03329608495073E-11 |
| Normal-vs-Age(61-80Yrs) |
1.45750078672791E-11 |
| Normal-vs-Age(81-100Yrs) |
2.843700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.550200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.256800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.398200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.912800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.058600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.728600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.90093999999918E-05 |
| Classical-VS-Follicular |
6.439600E-02 |
| Classical-VS-Other |
7.231200E-01 |
| Classical-VS-Normal |
5.77637937482223E-12 |
| Tall-VS-Follicular |
8.70900000005115E-07 |
| Tall-VS-Other |
9.960300E-02 |
| Tall-VS-Normal |
1.79856129989275E-14 |
| Follicular-VS-Other |
8.030200E-01 |
| Follicular-VS-Normal |
1.55053999999488E-05 |
| Other-VS-Normal |
2.227800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62469999676063E-08 |
| Normal-vs-N1 |
4.33875158023511E-13 |
| N0-vs-N1 |
1.044340E-03 |
|
|
